Silent pulmonary artery dissection in a centenarian
Asumi Matsumoto1, Tatsuya Kawasaki1, Mayumi Takeoka2
1Department of Cardiology, Matsushita Memorial Hospital, Osaka, Japan.
Pulmonary artery dissection, a rare and fatal condition, was incidentally diagnosed in a 97-year-old woman via echocardiography. This centenarian has remained well for over two years without surgical intervention.
Area of Science:
- Cardiology
- Vascular Surgery
- Geriatric Medicine
Background:
- Pulmonary artery dissection (PAD) is an exceptionally rare and often fatal vascular emergency.
- Diagnosis of PAD is challenging due to its rarity and often non-specific symptoms.
- Transthoracic echocardiography is a key diagnostic tool in evaluating cardiac and vascular abnormalities.
Observation:
- A case report of a 97-year-old female patient presenting with heart failure.
- Incidental diagnosis of silent pulmonary artery dissection during routine transthoracic echocardiography.
- The patient was a centenarian, highlighting the potential for PAD in the elderly.
Findings:
- Successful non-surgical management of pulmonary artery dissection in an elderly patient.
- The patient demonstrated remarkable recovery and sustained well-being for over two years post-diagnosis.
- Echocardiography proved effective in diagnosing a rare vascular condition in a challenging patient demographic.
Implications:
- This case suggests that non-surgical management may be a viable option for select elderly patients with pulmonary artery dissection.
- Highlights the importance of echocardiography in identifying rare cardiovascular pathologies, even in asymptomatic or 'silent' cases.
- Underscores the resilience of centenarians and the potential for favorable outcomes in rare diseases with conservative management.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...


